9-ING-41 in Patients With Advanced Cancers
Actuate Therapeutics Inc.
Actuate Therapeutics Inc.
Hoffmann-La Roche
Monte Rosa Therapeutics, Inc
Innoblative Designs, Inc.
Adela, Inc
OncoNano Medicine, Inc.
Massive Bio, Inc.
Incyte Corporation
AVM Biotechnology Inc
Tempus AI
Intensity Therapeutics, Inc.
RAPT Therapeutics, Inc.
Cyteir Therapeutics, Inc.
Taproot Health
VitaMed Research LLC
Sanguine Biosciences
Celldex Therapeutics
Eisai Inc.
Cellestia Biotech AG
Corvus Pharmaceuticals, Inc.
Hoffmann-La Roche
Fate Therapeutics
Pfizer
Genzada Pharmaceuticals USA, Inc.
Blue Note Therapeutics
Eli Lilly and Company
GlaxoSmithKline
AstraZeneca
Celgene
iOMEDICO AG
LEO Pharma
AbbVie
Novartis
Incyte Corporation
Amgen
Lytix Biopharma AS
sigma-tau i.f.r. S.p.A.
Incyte Corporation
GlaxoSmithKline
Sandoz
Valerio Therapeutics
INSYS Therapeutics Inc
Altor BioScience
Novartis
Mast Therapeutics, Inc.
Cylene Pharmaceuticals
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Amgen
Amgen
Pfizer